First Tracks Biotherapeutics Inc
TRAX | NASDAQ
$44.51
-$0.57 (-1.26%)
Nov 2, 2026, 12:12 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|
Net Income | -33.37M | -50.48M | -47.2M |
Depreciation & Amortization | 207K | 125K | 606K |
Stock-Based Compensation | n/a | 11.5M | 7.75M |
Other Working Capital | -12.45M | 2.16M | -905K |
Other Non-Cash Items | 8.47M | -8K | -1.67M |
Deferred Income Tax | n/a | n/a | n/a |
Change in Working Capital | -7.22M | 6.3M | -4.5M |
Operating Cash Flow | -31.92M | -32.56M | -45.01M |
Capital Expenditures | -25K | -17K | -35K |
Cash Acquisitions | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -122.55M |
Sales Maturities Of Investments | n/a | 35M | 137.43M |
Other Investing Acitivies | n/a | n/a | n/a |
Investing Cash Flow | -25K | 34.98M | 14.85M |
Debt Repayment | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a |
Other Financial Acitivies | -327.2M | 7.85M | 5.72M |
Financial Cash Flow | -48.51M | 7.85M | 5.72M |
Net Cash Flow | -80.45M | 10.27M | -24.44M |
Free Cash Flow | -31.94M | -32.58M | -45.04M |
Adj. Free Cash Flow | -31.94M | -44.08M | -52.79M |
Maintenance CapEx | -25K | -17K | -35K |
Growth CapEx | n/a | n/a | n/a |
Owner Earnings | -31.94M | -32.58M | -45.04M |
Add to Watchlist
Select watchlists to add or remove TRAX